COCRYSTAL PHARMA, INC. (COCP) Operating income 2016–2025
COCRYSTAL PHARMA, INC. (COCP) annual operating income history from SEC filings — each fiscal year as reported.
-$9.0MFY2025 · since FY2016: -$105.8M → -$9.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.0M | +49.6% |
| FY2024 | -$17.9M | +3.7% |
| FY2023 | -$18.6M | +52.2% |
| FY2022 | -$38.8M | -173.0% |
| FY2021 | -$14.2M | -48.4% |
| FY2020 | -$9.6M | +80.2% |
| FY2019 | -$48.4M | +23.1% |
| FY2018 | -$62.9M | -661.6% |
| FY2017 | -$8.3M | +92.2% |
| FY2016 | -$105.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice